TRUST CO OF VERMONT - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$5,391,857
-9.6%
52,934
-10.4%
0.36%
-6.4%
Q2 2023$5,964,387
+4.9%
59,106
-4.3%
0.39%
-2.0%
Q1 2023$5,684,220
+0.4%
61,785
-1.0%
0.40%
-4.3%
Q4 2022$5,660,293
+13.0%
62,393
-5.3%
0.42%
+4.8%
Q3 2022$5,009,000
-11.8%
65,900
-1.9%
0.40%
-8.8%
Q2 2022$5,681,000
-5.8%
67,207
-2.2%
0.43%
+6.4%
Q1 2022$6,031,000
-0.9%
68,728
-1.2%
0.41%
+6.2%
Q4 2021$6,086,000
+2.6%
69,570
-4.1%
0.38%
-9.0%
Q3 2021$5,934,000
-12.2%
72,568
-2.0%
0.42%
-10.4%
Q2 2021$6,757,000
+6.2%
74,060
-0.5%
0.47%
-1.3%
Q1 2021$6,364,000
-18.1%
74,441
-9.5%
0.48%
-22.9%
Q4 2020$7,768,000
+6.0%
82,267
-2.4%
0.62%
-7.7%
Q3 2020$7,327,000
-3.4%
84,251
-3.0%
0.67%
-10.4%
Q2 2020$7,587,000
-15.9%
86,870
-20.7%
0.75%
-11.4%
Q1 2020$9,026,000
-12.6%
109,481
+0.4%
0.84%
+8.3%
Q4 2019$10,330,000
+7.9%
109,099
-1.0%
0.78%
+1.6%
Q3 2019$9,572,000
-6.4%
110,149
-1.6%
0.77%
-9.5%
Q2 2019$10,226,000
-5.7%
111,995
-0.7%
0.85%
-9.0%
Q1 2019$10,845,000
+11.1%
112,796
-0.9%
0.93%
-1.2%
Q4 2018$9,763,000
-0.8%
113,771
-0.4%
0.94%
+13.6%
Q3 2018$9,845,000
+14.3%
114,257
+0.2%
0.83%
+7.6%
Q2 2018$8,613,000
-5.7%
114,015
+0.9%
0.77%
-10.4%
Q1 2018$9,132,000
-2.8%
112,950
+1.0%
0.86%
-1.1%
Q4 2017$9,391,000
-1.5%
111,857
+0.7%
0.87%
-8.0%
Q3 2017$9,535,000
+3.2%
111,070
+0.4%
0.95%0.0%
Q2 2017$9,236,000
+16.1%
110,651
+3.3%
0.95%
+10.2%
Q1 2017$7,957,000
+3.9%
107,143
+1.9%
0.86%
-2.5%
Q4 2016$7,656,000
+2.7%
105,105
+11.4%
0.88%
-5.6%
Q3 2016$7,452,000
-0.0%
94,377
+4.5%
0.93%
-5.7%
Q2 2016$7,453,000
+19.3%
90,321
+4.8%
0.99%
+13.3%
Q1 2016$6,245,000
+0.8%
86,215
+19.7%
0.87%
-1.5%
Q4 2015$6,194,000
-4.2%
71,996
+2.3%
0.89%
-11.9%
Q3 2015$6,467,000
-6.0%
70,358
+0.6%
1.01%
+0.6%
Q2 2015$6,878,000
-0.6%
69,936
-0.4%
1.00%
-0.6%
Q1 2015$6,922,000
+5.0%
70,201
-1.3%
1.01%
+4.8%
Q4 2014$6,591,000
-1.8%
71,122
-0.2%
0.96%
-5.3%
Q3 2014$6,711,000
+4.4%
71,296
+0.4%
1.02%
+2.3%
Q2 2014$6,430,000
+8.1%
71,019
+1.5%
0.99%
+1.8%
Q1 2014$5,950,000
+6.2%
69,981
+0.4%
0.97%
+3.7%
Q4 2013$5,603,000
+8.2%
69,711
+3.2%
0.94%
-1.2%
Q3 2013$5,180,000
+12.9%
67,535
+4.0%
0.95%
+6.0%
Q2 2013$4,590,00064,9110.90%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders